Most consumers love ‘try before you buy’ opportunities, especially when the goods or services involved are big ticket items laden with new technology not yet fully understood by the general population. Such test runs are effectively a way for potential purchasers to undertake some due diligence on a product before deciding to take the plunge
Read More
For many, a bad night’s sleep can be chalked up to a late night out, stress and such. However, multiple nights of restless sleep could mean something more. Insomnia is among the two most common sleep disorders in Australia, with the second being obstructive sleep apnea. About 60% of Aussies display symptoms of insomnia. With
Read More
On the heels of a mixed recreational vehicles (RVs) market, global tourism operator Tourism Holdings Limited (ASX: THL) has finalised the sale of its 14.14% stake in Camplify Holdings Limited (ASX: CHL), a peer-to-peer RV rental operator. The sale, based on a per-share price of $1.90, fetched approximately $19.2 million in gross proceeds for thl.
Read More
With more than 500,000 migrants arriving in Australia annually, most on student and working visas quickly find that housing becomes their largest expense while trying to integrate into a new culture. It’s why so many get slugged by exorbitant foreign exchange and admin fees when trying to navigate Australia’s banking system, and also why Rent.com.au
Read More
Medical device company Atomo Diagnostics (ASX: AT1) has locked in purchase orders from Viatris Healthcare Pty Ltd amounting to approximately $970,000 for HIV Self-Tests. These tests, manufactured by Atomo under the Mylan brand, are designated for supply to several Low- and Middle-Income Countries (LMICs). The orders are scheduled for production during the second half of
Read More
Despite global efforts, food waste remains a challenging problem to solve. Each year, 1.3 billion tons of food is wasted due to poor handling, costing the global economy $1.5 trillion. This waste contributes 6-8% of annual greenhouse gas emissions and, what’s more, if saved, it could have fed about 1.26 billion people. No doubt, food
Read More
Aussie clinical stage biotech company Cynata Therapeutics (ASX: CYP) has marked a milestone in its Phase 2 clinical trial of CYP-001 for high-risk acute graft versus host disease (aGvHD) with the enrolment and treatment of its first patient. High-risk acute graft versus host disease (aGvHD) is a serious complication that can occur after a stem
Read More
While the artificial intelligence industry has been a big winner from the bumper financials delivered by semiconductor company NVIDIA last month, shareholders of semiconductor equipment firm Revasum (ASX: RVS) are still waiting to see the share price gains delivered by peers. The wait could take another two weeks, with Revasum extending its voluntary suspension in
Read More
With a name that evoked interest amid the Buy-Now-Pay-Later boom led by Afterpay, it came as no surprise that Beforepay (ASX: B4P) drew initial interest in its lending products before shares tanked as the BNPL bubble burst. But unlike its more high profile peer, Beforepay has turned things around financially and with better tech, is
Read More
Online travel aggregator Jayride (ASX: JAY) had little choice but to undertake a comprehensive strategic review following dwindling profit margins. In November 2023, during a Shareholder Address, Chairman Rod Cuthbert acknowledged the pit, or “challenging position”, the Company was in. Founded in 2012, Jayride aggregates ride service companies and distributes them to travellers at Jayride.com,
Read More
